Stockreport

Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements [Yahoo! Finance]

Alumis Inc.  (ALMS) 
PDF long-term clinical responses and was well tolerated; Phase 3 ONWARD program data readout now expected 1Q 2026 – – Presented Phase 1 clinical data at ACTRIMS 2025 demon [Read more]